Day K P
Department of Biology, Imperial College of Science, Technology and Medicine, Prince Consort Road, London SW7 2BB, UK.
Parasitol Today. 1991 Dec;7(12):341-3. doi: 10.1016/0169-4758(91)90215-a.
Residents of areas endemic for lymphatic filariasis are continually exposed to infection with mosquito-transmitted infective larvae (L3), some of which survive to become adult worms and subsequently produce micro filarial (mf) transmission stages. The question of whether naturally acquired resistance occurs in adult residents of endemic areas has recently become of interest as the development of molecular vaccines against filarial parasites is being considered(1,2). There have been two epidemiological approaches to demonstrate acquired resistance to Filariasis in human populations. In this review Karen Day examines both approaches in the context of an immunoepidemiological study of bancroftian filariasis in Papua New Guinea (PNG). The merits of each as a conceptual framework for studies of protective immunity in lymphatic filariasis will be discussed.
淋巴丝虫病流行地区的居民持续暴露于由蚊子传播的感染性幼虫(L3),其中一些幼虫存活下来成为成虫,随后产生微丝蚴(mf)传播阶段。随着针对丝虫寄生虫的分子疫苗的研发受到关注,流行地区成年居民是否会产生自然获得性抗性的问题最近引起了人们的兴趣(1,2)。有两种流行病学方法可用于证明人群对丝虫病产生了获得性抗性。在这篇综述中,凯伦·戴在巴布亚新几内亚(PNG)班氏丝虫病免疫流行病学研究的背景下审视了这两种方法。将讨论每种方法作为淋巴丝虫病保护性免疫研究概念框架的优点。